SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 214 filers reported holding SAGE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,532,901 | -13.8% | 74,485 | +96.8% | 0.00% | 0.0% |
| Q2 2023 | $1,779,330 | +445.2% | 37,842 | +386.5% | 0.00% | – |
| Q1 2023 | $326,364 | -81.3% | 7,778 | -83.0% | 0.00% | -100.0% |
| Q4 2022 | $1,745,705 | +403.1% | 45,771 | +417.0% | 0.00% | – |
| Q3 2022 | $347,000 | -98.8% | 8,854 | -99.0% | 0.00% | -100.0% |
| Q1 2022 | $27,958,000 | -19.0% | 844,652 | +4.1% | 0.03% | -14.7% |
| Q4 2021 | $34,518,000 | +32.3% | 811,434 | +37.8% | 0.03% | +21.4% |
| Q3 2021 | $26,100,000 | +11.8% | 589,039 | +43.4% | 0.03% | +12.0% |
| Q2 2021 | $23,335,000 | +24.8% | 410,753 | +64.4% | 0.02% | +8.7% |
| Q1 2021 | $18,704,000 | +29.3% | 249,888 | +49.5% | 0.02% | +21.1% |
| Q4 2020 | $14,461,000 | – | 167,157 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 179,200 | $29,516,000 | 16.65% |
| TRV GP II, LLC | 547,916 | $90,247,000 | 16.25% |
| Opus Point Partners Management, LLC | 71,000 | $11,694,000 | 10.12% |
| Casdin Capital, LLC | 250,000 | $41,178,000 | 10.03% |
| RA Capital Management | 455,173 | $74,972,000 | 6.27% |
| Crawford Lake Capital Management, LLC | 154,278 | $25,411,000 | 6.00% |
| Palo Alto Investors LP | 810,806 | $133,548,000 | 5.75% |
| GREAT POINT PARTNERS LLC | 200,000 | $32,942,000 | 5.62% |
| BB BIOTECH AG | 1,042,439 | $171,700,000 | 4.84% |
| Crawford Lake Capital Management, LLC | 92,300 | $15,203,000 | 3.59% |